Amgen (NASDAQ:AMGN) announced on Monday that its new weight loss treatment, MariTide, resulted in an average weight loss of ...

A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...

Novo Nordisk has ended its partnership with Hims & Hers Health Inc., citing “deceptive marketing” and the selling of ...

Amgen is expanding development plans for its weight-loss drug MariTide to study its use for heart disease and sleep apnea.

Americans taking Ozempic could be at risk of deadly heat stroke amid soaring temperatures, experts warn. The warning comes as ...

Each project team comprises members from at least two JHU entities who aim to solve a complex problem and expand the horizons of knowledge.

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.